« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 1
, Pages 25-31
, January 2008
Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection by local sustained release of vancomycin
References
- Local treatment of prosthetic vascular graft infection with multivesicular liposome-encapsulated amikacin. J Surg Res. 1998;74:54–58
- . Mechanism of late prosthetic vascular graft infection. Cardiovasc Surg. 1997;5:486–489
- Rifampin and triclosan but not silver is effective in preventing bacterial infection of vascular Dacron graft material. Eur J Endovasc Surg. 2003;26:550–557
- . Current options in prosthetic vascular graft infection. Am Surg. 1998;64:39–46
- . Methicillin-resistant Staphylococcus aureus infection in vascular surgical patients. Ann R Coll Surg Engl. 2001;83:158–163
- . The impact of MRSA on vascular surgery. Eur J Endovasc Surg. 2001;22:211–214
- Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg. 2002;102:238–247
- Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection. J Vasc Surg. 2006;44:377–382
- . Protein bonding on biodegradable poly(L-lactide-co-caprolactone) membrane for esophageal tissue engineering. Biomaterials. 2006;27:68–78
- New polymers for drug delivery systems in orthopaedics: in vivo biocompatibility evaluation. Biomed Pharmacother. 2004;58:411–417
- Subcutaneous tissue distribution of vancomycin from a fibrin glue/Dacron graft carrier. J Biomed Mater Res. 1997;36:564–567
- Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. J Antimicrobial Chemother. 2000;46:751–756
- . Gelatin-sealed Dacron graft is not more susceptible to MRSA infection than PTFE graft. Eur J Endovasc Surg. 2006;32:425–430
- . Local delivery of vancomycin for prophylaxis of prosthetic device related infections. Pharm Res. 2005;22:563–572
- Limitations in the use of rifampicin-gelatin grafts against virulent organisms. J Vasc Surg. 2002;35:779–785
- In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg. 2000;31:837–838
- Total excision and extra-anatomical bypass for aortic graft infection. Am J Surg. 1991;162:145–149
- . Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg. 2000;32:451–461
- The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg. 1999;178:136–140
- . Pedicled muscle flaps in the management of infected aortofemoral grafts. Cardiovasc Surg. 1994;2:70–77
- . A new method for the treatment of graft infection in the thoracic aorta: in situ preservation. Ann Thorac Surg. 1999;67:1994–1996
PII: S0022-5223(07)01199-3
doi: 10.1016/j.jtcvs.2007.06.027
© 2008 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 1
, Pages 25-31
, January 2008
